Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2696 Results
Penn Study: Incisionless Transcatheter Aortic Valve Replacement Surgery Associated with Shorter Hospital Stays

Penn Study: Incisionless Transcatheter Aortic Valve Replacement Surgery Associated with Shorter Hospital Stays

New research from Penn Medicine shows that incisionless transcatheter aortic valve replacement (TAVR) surgery cuts length of hospital stay by 30 percent and has no impact on post-operative vascular complication rates when compared with conventional transfemoral TAVR, which requires an incision in the groin.

Lee-Ann Donegan

Link Between Ritual Circumcision Procedure and Herpes Infection in Infants Examined by Penn Medicine Analysis

Link Between Ritual Circumcision Procedure and Herpes Infection in Infants Examined by Penn Medicine Analysis

A rare procedure occasionally performed during Jewish circumcisions that involves direct oral suction is a likely source of  herpes simplex virus type 1 (HSV-1) transmissions documented in infants between 1988 and 2012, a literature review conducted by Penn Medici

Steve Graff

Atomic Structure of Key Muscle Component Revealed in Penn Study

Atomic Structure of Key Muscle Component Revealed in Penn Study

Actin is the most abundant protein in the body, and when you look more closely at its fundamental role in life, it’s easy to see why. It is the basis of most movement in the body, and all cells and components within them have the capacity to move: muscle contracting, heart beating, blood clotting, and nerve cells communicating, among many other functions.

Karen Kreeger

Penn Study: Metabolic Enzyme Stops Progression of Most Common Type of Kidney Cancer

Penn Study: Metabolic Enzyme Stops Progression of Most Common Type of Kidney Cancer

In an analysis of small molecules called metabolites used by the body to make fuel in normal and cancerous cells in human kidney tissue, a research team from the Perelman School of Medicine at the University of Pennsylvania identified an enzyme key to applying the brakes on tumor growth.

Karen Kreeger

Potassium Supplements May Increase Survival in Patients Taking Diuretics for Heart Failure, Penn Study Suggests

Potassium Supplements May Increase Survival in Patients Taking Diuretics for Heart Failure, Penn Study Suggests

Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking prescription potassium supplements together with loop diuretics for heart failure have better survival rates than patients taking diuretics without the potassium. Moreover, the degree of benefit increases with higher diuretic doses.

Steve Graff

Penn Medicine Study: Liver Transplant Patients Who Receive Organs from Living Donors More Likely to Survive than Those Who Receive Organs from Deceased Donors

Penn Medicine Study: Liver Transplant Patients Who Receive Organs from Living Donors More Likely to Survive than Those Who Receive Organs from Deceased Donors

Research derived from early national experience of liver transplantation has shown that deceased donor liver transplants offered recipients better survival rates than living donor liver transplants, making them the preferred method of transplantation for most physicians. Now, the first data-driven study in over a decade disputes this notion.

Lee-Ann Donegan

New Penn Study Shows Drinking Alcohol, Even Light-to-Moderate Amounts, Provides No Heart Health Benefit

New Penn Study Shows Drinking Alcohol, Even Light-to-Moderate Amounts, Provides No Heart Health Benefit

Reducing the amount of alcoholic beverages consumed, even for light-to-moderate drinkers, may improve cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index (BMI) and blood pressure, according to a new multi-center study published in The BMJ and co-led by the Pere

Katie Delach

Penn to Lead $22.5 Million Project on Restoring Memory Loss

Penn to Lead $22.5 Million Project on Restoring Memory Loss

A team of scientists and physicians at the University of Pennsylvania will lead a four-year effort worth as much as $22.5 million to develop next-generation technologies to restore memory function in people who suffer from memory loss due to disease or traumatic injury.

Evan Lerner